亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

3-Hydroxy-Propanamine Derived Neuronal Reuptake Inhibitors

总结: Antidepressants such as Prozac, Paxil and Zoloft, are characterized by an ability to selectively block reuptake of serotonin (5-HT). Selective NE-reuptake inhibitor antidepressants such as Tomoxetine and Vivalan have also been developed. Effexor and Serzone have been termed SNRI antidepressants because they inhibit 5-HT and NE reuptake with similar potency. However, these present drugs are ineffective to some patients. Only new generation of drugs possess reuptake inhibition profile different from those currently known can solve the problem.

The invention relates to the new class of antidepressant compounds, which exhibit synaptosomal reuptake inhibition of neurotransmitters such as serotonin (5-HT), norephinephrine (NE), and dopamin (DA) simultaneously. These new compounds possess special reuptake inhibition profile. The antidepressant properties of these compounds were assayed. The best of these new compounds bind to the transporter protein 175 times stronger than serotonin itself. These compounds will therefore effectively block synaptosomal reuptake of serotonin.

技术优势: 1. Comparatively reduced therapeutic dosages of antidepressant compounds
2. Less side effects
3. More effective
4. Wide range of usage

附加资料: Patent Number: US6069177A
Application Number: US1997889357A
Inventor: Carlier, Paul R. | Richelson, Elliott | Lo, Ching Kam | Lo, Man Chu
Priority Date: 8 Jul 1997
Priority Number: US6069177A
Application Date: 8 Jul 1997
Publication Date: 30 May 2000
IPC Current: C07C021528
US Class: 514652 | 564349
Assignee Applicant: The Hong Kong University of Science & Technology
Title: 3-Hydroxy-propanamine derived neuronal reuptake inhibitors
Usefulness: 3-Hydroxy-propanamine derived neuronal reuptake inhibitors
Summary: USE The derivative represents a kind of new-type mental state therapeutic medicine as antidepressant.
Novelty: 3-hydroxyl-propylamide derived nerve cell reabsorption inhibitor useful as a new-type mental state therapeutic medicine as a antidepressant

欲了解更多信息，请点击这里